News
Four previously tested AI diagnostic algorithms for skin cancer demonstrated lower sensitivity and specificity when tested on ...
A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.
This study excluded uveal melanoma, but included all other subtypes provided they had progressed on previous therapy. With this broad population of patients with melanoma, those who received an ...
Melanoma is one of the most common cancers and treating it can be particularly stressful for expectant mothers.
Recent reports show that experts have seen a rise in melanoma cases in Massachusetts, especially among younger women. NewsCenter 5 spoke to Dr. Jeff Yu, a dermatologist at Mass. General Hospital ...
Mitochondrial DNA emerges as a key factor in melanoma checkpoint inhibitor resistance, revealing new potential biomarker for patients.
Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the needle in resected skin cancer. After revealing in February that ...
Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma in Ongoing Multicenter Study at the 2025 American Society of Clinical Oncology (ASCO) Annual ...
Mom’s Melanoma Found in Unlikely Place: ‘Is This a Death Sentence?’ Michaela Peacock's hair stylist noticed that she had a mole on her scalp that had changed, prompting her to seek medical ...
Using multi-omics analysis, the team identified five adenosine phosphate signaling subtypes in melanoma, categorized into two major metaprograms: metabolic and inflammatory.
With UK skin cancer cases rising, GPs have been encouraged to adopt dermoscopy, expand training, and consider lower-risk skin surgeries.
Teen Diagnosed with Stage 3 Melanoma at 15 Says Doctors Initially Dismissed Cancer Symptom as Sign of ‘Puberty’ “It’s very important that we take care of ourselves, and I think a lot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results